Drug Price Trends for NDC 00487-9801

Average Pharmacy Cost for 00487-9801

Drug Name	NDC	Price/Unit ($)	Unit	Date
IPRATROPIUM BR 0.02% SOLN	00487-9801-60	0.10851	ML	2025-04-23
IPRATROPIUM BR 0.02% SOLN	00487-9801-01	0.10299	ML	2025-04-23
IPRATROPIUM BR 0.02% SOLN	00487-9801-25	0.09872	ML	2025-04-23
IPRATROPIUM BR 0.02% SOLN	00487-9801-30	0.10299	ML	2025-04-23
IPRATROPIUM BR 0.02% SOLN	00487-9801-60	0.10606	ML	2025-03-19
IPRATROPIUM BR 0.02% SOLN	00487-9801-01	0.10030	ML	2025-03-19
IPRATROPIUM BR 0.02% SOLN	00487-9801-30	0.10030	ML	2025-03-19

Best Wholesale Price for NDC 00487-9801

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
No data available in table

Market Analysis and Price Projections for Ipratropium Bromide Inhalation Solution (NDC: 00487-9801)

The pharmaceutical market is constantly evolving, with drug prices and market dynamics playing crucial roles in shaping the industry landscape. In this comprehensive analysis, we'll delve into the market trends and price projections for Ipratropium Bromide Inhalation Solution, specifically focusing on the NDC code 00487-9801.

Understanding Ipratropium Bromide Inhalation Solution

Ipratropium Bromide Inhalation Solution is a bronchodilator medication used to treat chronic obstructive pulmonary disease (COPD) and other respiratory conditions. It works by relaxing the muscles in the airways, making breathing easier for patients[5].

Key Features and Indications

• Bronchodilator action
• Used alone or in combination with other medications
• Indicated for COPD and related respiratory issues

Current Market Landscape

The pharmaceutical industry is experiencing significant changes, with drug prices and market trends playing pivotal roles in shaping the future of healthcare.

Overall Drug Price Trends

Recent projections indicate a 3.8% increase in drug prices, largely driven by specialty pharmaceuticals[2]. This trend is expected to impact various medications, including respiratory drugs like Ipratropium Bromide Inhalation Solution.

Factors Influencing Price Changes

Several factors contribute to the evolving pricing landscape:

1. Specialty pharmacy utilization
2. Increasing demand for weight loss drugs
3. Expansion of gene therapies
4. Supply chain challenges

"Many hospitals around the country experienced a challenging 2023, including drug shortages and rising drug costs. Managing pharmacy expenditures and strengthening the supply chain is more important than ever." - Carina Dolan, Associate Vice President, Clinical Oncology, Pharmacoeconomics and Market Insights, Vizient[2]

Pricing Analysis for NDC 00487-9801

Let's examine the specific pricing information available for Ipratropium Bromide Inhalation Solution with NDC 00487-9801.

Current Pricing

Based on the search results, the current pricing information for this specific NDC is not directly provided. However, we can infer some insights from the available data.

Historical Price Trends

While exact historical prices are not given, the pharmaceutical industry has seen consistent price increases over the years. For respiratory medications like Ipratropium Bromide, these increases have been influenced by factors such as manufacturing costs, research and development expenses, and market demand.

Market Projections and Future Outlook

To understand the potential future pricing for Ipratropium Bromide Inhalation Solution, we need to consider broader market trends and industry projections.

Short-term Projections (2025-2026)

1. Overall drug price inflation is expected to grow at 3.8% in the near term[2].
2. Specialty pharmaceuticals, including respiratory medications, are likely to see higher price increases.
3. The implementation of the Medicare Drug Price Negotiation Program may impact pricing strategies for various drugs, potentially including Ipratropium Bromide[6].

Long-term Outlook (2026-2032)

Looking further ahead, several factors may influence the pricing and market dynamics for Ipratropium Bromide Inhalation Solution:

1. Continued focus on value-based healthcare
2. Advancements in drug delivery technologies
3. Potential generic competition
4. Evolving regulatory landscape

Impact of Healthcare Policies and Regulations

Government policies and regulations play a significant role in shaping drug prices and market access.

Medicare Drug Price Negotiation Program

The implementation of negotiated prices under this program, set to begin in 2026, could have ripple effects across the pharmaceutical industry[6]. While Ipratropium Bromide may not be directly targeted, the overall market dynamics could be influenced by these negotiations.

State-level Initiatives

Various states are implementing their own measures to control drug prices and increase transparency. For example, New York requires public reporting of drug price increases[10]. Such initiatives may impact pricing strategies for medications like Ipratropium Bromide Inhalation Solution.

Competitive Landscape

Understanding the competitive environment is crucial for projecting future pricing trends for Ipratropium Bromide Inhalation Solution.

Key Market Players

While specific market share data for NDC 00487-9801 is not provided, major players in the respiratory medication market include:

1. Nephron Pharmaceuticals Corporation (manufacturer of NDC 00487-9801)[5]
2. Other generic manufacturers
3. Branded respiratory medication producers

Potential Market Entrants

The respiratory medication market may see new entrants in the coming years, potentially impacting pricing dynamics for established products like Ipratropium Bromide Inhalation Solution.

Technological Advancements and Their Impact

Innovations in drug development and delivery systems could influence the future of Ipratropium Bromide Inhalation Solution.

Smart Inhalers and Digital Health

The integration of smart technologies with inhalation devices may add value to respiratory medications, potentially justifying price adjustments.

Novel Drug Delivery Systems

Advancements in formulation and delivery methods could lead to improved versions of Ipratropium Bromide, potentially affecting pricing strategies.

Global Market Trends and Their Influence

While our focus is on the U.S. market, global trends can significantly impact domestic pricing and availability.

Supply Chain Resilience

The pharmaceutical industry is increasingly focusing on supply chain optimization and resilience. More than 85% of biopharma executives surveyed plan to invest in data, AI, and digital tools to build supply chain resiliency in 2025[7].

Emerging Markets and Manufacturing Shifts

Changes in global manufacturing patterns and the growth of emerging pharmaceutical markets may influence the production and pricing of generic medications like Ipratropium Bromide Inhalation Solution.

Patient Demographics and Demand Projections

Understanding the target patient population is crucial for projecting future demand and pricing trends.

COPD Prevalence and Trends

The prevalence of COPD and other respiratory conditions will play a significant role in shaping the demand for Ipratropium Bromide Inhalation Solution.

Aging Population

As the global population ages, the incidence of respiratory conditions is likely to increase, potentially driving up demand for medications like Ipratropium Bromide.

Pricing Strategies and Market Access

Pharmaceutical companies employ various strategies to balance profitability with market access and patient affordability.

Value-Based Pricing

There's a growing trend towards value-based pricing in healthcare, which could influence how medications like Ipratropium Bromide are priced in the future.

Patient Assistance Programs

Manufacturers may implement or expand patient assistance programs to maintain access to their medications in the face of pricing pressures.

Future Research and Development

Ongoing research in the field of respiratory medicine could impact the market position and pricing of Ipratropium Bromide Inhalation Solution.

Combination Therapies

The development of new combination therapies, such as the existing Ipratropium Bromide and Albuterol Sulfate solution[9], may influence pricing strategies for individual components.

Novel Treatment Approaches

Breakthroughs in COPD treatment could potentially disrupt the market for existing medications like Ipratropium Bromide.

Key Takeaways

1. The pharmaceutical market is projected to see a 3.8% increase in drug prices, driven largely by specialty medications.
2. Specific pricing data for Ipratropium Bromide Inhalation Solution (NDC 00487-9801) is limited, but it's likely to be influenced by broader market trends.
3. Government policies, including the Medicare Drug Price Negotiation Program, may impact future pricing strategies.
4. Technological advancements and global market trends will play crucial roles in shaping the future of respiratory medications.
5. Patient demographics, particularly the aging population and COPD prevalence, will influence demand and pricing.
6. Value-based pricing and patient assistance programs may become increasingly important in maintaining market access.
7. Ongoing research and development in respiratory medicine could potentially disrupt the market for existing treatments.

FAQs

1. Q: How often is Ipratropium Bromide Inhalation Solution typically used? A: Ipratropium Bromide Inhalation Solution is usually administered 3-4 times daily, or as prescribed by a healthcare provider.

2. Q: Are there any potential side effects of using Ipratropium Bromide Inhalation Solution? A: Common side effects may include headache, dizziness, and dry mouth. Patients should consult their healthcare provider for a complete list of potential side effects.

3. Q: How does the pricing of Ipratropium Bromide compare to other COPD medications? A: While specific pricing comparisons are not provided in the available data, Ipratropium Bromide is generally considered a cost-effective option compared to some newer COPD treatments.

4. Q: Will the Medicare Drug Price Negotiation Program directly affect the price of Ipratropium Bromide Inhalation Solution? A: While the program may not directly target Ipratropium Bromide, its implementation could have broader effects on the pharmaceutical market, potentially influencing pricing strategies for various medications.

5. Q: How might future technological advancements impact the use and pricing of Ipratropium Bromide Inhalation Solution? A: Innovations such as smart inhalers and novel drug delivery systems could potentially add value to respiratory medications like Ipratropium Bromide, which may influence future pricing strategies.

Sources cited: [2] https://www.vizientinc.com/newsroom/news-releases/2024/vizient-projects-3-8-drug-price-increase-driven-by-specialty-pharmaceuticals [5] https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=db8095db-d1fd-4099-9fb1-d1ad4e284976 [6] https://www.cms.gov/files/document/fact-sheet-negotiated-prices-initial-price-applicability-year-2026.pdf [7] https://www.zs.com/insights/pharmaceutical-trends-2025-outlook-ai-supplychain-and-beyond [9] https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ae35ec1f-526a-49bf-8262-c50e40190d1f [10] https://www.dfs.ny.gov/system/files/documents/2024/11/Drug_Price_Increases_Public_Reporting_November_29_2024.xlsx